Cystic fibrosis drug approved for patients aged 6-11 years worked well in clinical practice

Acta Paediatr. 2021 Jan;110(1):228-229. doi: 10.1111/apa.15519. Epub 2020 Sep 16.

Authors

Ioanna Loukou¹, Argyri Petrocheilou¹, Maria Moustaki¹, Christina N Katsagoni¹, Konstantinos Douros²

Affiliations

¹ Cystic Fibrosis Department, Agia Sofia Children's Hospital, Athens, Greece.
² Pediatric Allergy and Respiratory Unit, 3rd Department of Pediatrics, School of Medicine, "Attikon" University Hospital, National and Kapodistrian University of Athens, Athens, Greece.

PMID: 32762058
DOI: 10.1111/apa.15519

No abstract available

MeSH terms

Child
Cystic Fibrosis Transmembrane Conductance Regulator
Cystic Fibrosis* / drug therapy
Humans
Pharmaceutical Preparations*

Substances

Pharmaceutical Preparations
Cystic Fibrosis Transmembrane Conductance Regulator